申请人:SmithKline Beecham Corporation
公开号:US06399656B1
公开(公告)日:2002-06-04
This invention relates to substituted heteroanilide compounds which are modulators, agonists or antagonists, of the CCR5 receptior. In addition, this invention relates to the treatment and prevention of disease states mediatd by CCR5.
本发明涉及替代杂环苯胺化合物,其为CCR5受体的调节剂、激动剂或拮抗剂。此外,本发明涉及通过CCR5介导的疾病状态的治疗和预防。